Диагностика метахронного рака молочной железы

Natalya Lepkova, В. Н. Богатырев, Лактионов Константин Павлович et al. · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2007

The purpose of this study was to identify clinical and biological factors of prognosis in patients with primary breast cancer and to asses their influence on the risk of metachronous cancer development. We studied tumor cells from primary or metachronous breast cancer in 37 patients using DNA flow cytofluorometry. Both (primary and metachronous tumors) had similar ploidy in 94.6% of cases. In 37.8% of patients with metachronous breast cancer the tumor was aneuploid with loss of chromosomal material. DNA flow cytofluorometry findings in combination with clinical factors such as young age and early disease predict development of metachronous breast cancer with an 80% accuracy.

Cited by 0 works.

Authors